Understanding Mounjaro vs Wegovy Dosing Differences
Mounjaro and Wegovy Equivalent Doses: Key Differences
When comparing Mounjaro and Wegovy equivalent doses, it's essential to understand that these prescription-only medicines work through different mechanisms and cannot be directly converted dose-for-dose. Wegovy (semaglutide) follows a 5-stage escalation from 0.25mg to 2.4mg maintenance, while Mounjaro (tirzepatide) uses a 6-stage protocol from 2.5mg to 15mg maintenance. The dosing schedules reflect each medication's unique pharmacological profile rather than equivalent therapeutic effects.
Both treatments require careful dose escalation to minimise potential side effects, but their titration schedules differ significantly. Wegovy's escalation occurs every 4 weeks over 16 weeks total, while Mounjaro typically escalates every 4 weeks over 20 weeks. At EverydayMeds, our prescribers assess which dosing protocol may be more suitable based on your individual clinical needs and weight management goals.
Mounjaro and Wegovy Equivalent Doses: Pricing Comparison
Understanding the cost implications of Mounjaro and Wegovy equivalent doses helps inform treatment decisions. Wegovy pricing at EverydayMeds ranges from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose, with new customers using code FIRST40 and returning customers using code DOSE25 at checkout. Our bundle options like the Intro Trio (0.25mg, 0.5mg & 1mg) at £299.99 provide convenient step-up dosing without multiple orders.
While Mounjaro follows a different pricing structure due to its higher milligram doses, both treatments represent significant investments in long-term weight management. Our 3-minute online clinical assessment determines eligibility for either option, with standard prescriber review within 3 working days or express 24-hour service available. Next-day cold-chain delivery ensures both medications arrive in optimal condition once approved.
Clinical Evidence for Mounjaro and Wegovy Equivalent Doses
Clinical trials demonstrate both Mounjaro and Wegovy's efficacy, though direct comparison of results isn't appropriate due to different trial designs and patient populations. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, as reported by Wilding et al. in the New England Journal of Medicine, 2021. The SELECT trial also showed a 20% reduction in major cardiovascular events.
Mounjaro's clinical programme, including the SURMOUNT trials, evaluated its dual GIP and GLP-1 receptor mechanism in separate study populations. Both medications require prescription alongside a reduced-calorie diet and increased physical activity, with individual results varying based on multiple factors including adherence, lifestyle modifications, and baseline characteristics.
How Wegovy Works in Mounjaro and Wegovy Equivalent Doses
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural fullness hormone GLP-1 to regulate appetite and promote satiety after smaller meals. The medication works on brain appetite centres to potentially reduce food cravings and help patients feel satisfied with smaller portion sizes. This mechanism supports weight management when combined with dietary modifications and increased physical activity, as part of a comprehensive approach to long-term weight control. The once-weekly FlexTouch pen delivery system maintains consistent semaglutide levels throughout the week, supporting sustained appetite regulation. Understanding this mechanism helps patients set realistic expectations about how Wegovy may support their weight management journey.
Ordering Process for Mounjaro and Wegovy Equivalent Doses
Accessing either Mounjaro or Wegovy through EverydayMeds begins with our 3-minute online clinical assessment, designed to evaluate your suitability for prescription weight management medication. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), considering factors like BMI, medical history, and previous weight loss attempts to determine which treatment may be most appropriate. Once approved, your medication is dispatched via next-day delivery using cold-chain temperature-controlled packaging to maintain medication integrity. This streamlined process ensures you can access expert weight management support without lengthy GP waiting times, while maintaining full clinical oversight and safety standards. Our GPhC-registered pharmacy (#9012878) ensures all medications meet UK quality and safety standards.
Storage and Practical Considerations for Mounjaro and Wegovy Equivalent Doses
Storage requirements represent a key practical difference when comparing Mounjaro and Wegovy equivalent doses. Wegovy must be stored in the fridge at 2-8°C before first use but can remain at room temperature below 30°C for up to 6 weeks once removed, offering significant travel flexibility compared to Mounjaro's 21-day room temperature limit. The Wegovy FlexTouch pen system provides user-friendly injection with clear dosing windows and safety features, while the mandatory dose escalation schedule prevents patients from rushing to higher doses too quickly. Each pen contains 4 weekly doses, requiring monthly prescription renewals during the escalation phase, then maintenance prescriptions once you reach the 2.4mg therapeutic dose. This structured approach supports both medication safety and treatment adherence throughout your weight management journey.
Mechanism Comparison in Mounjaro and Wegovy Equivalent Doses
The fundamental difference between Mounjaro and Wegovy equivalent doses lies in their receptor targeting mechanisms. Wegovy targets GLP-1 receptors exclusively, while Mounjaro activates both GIP and GLP-1 receptors simultaneously, creating distinct therapeutic profiles that cannot be directly compared dose-for-dose. This dual agonist approach in Mounjaro may influence appetite regulation, glucose metabolism, and weight loss through different pathways compared to Wegovy's single-receptor mechanism.
Both medications require careful clinical assessment to determine suitability, as individual patient factors influence treatment response regardless of the chosen mechanism. At EverydayMeds, our prescribers evaluate your medical history, weight management goals, and practical considerations like storage requirements to recommend the most appropriate option. Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you have access to expert guidance in choosing between these advanced weight management treatments.
Making Your Choice: Mounjaro and Wegovy Equivalent Doses
Choosing between Mounjaro and Wegovy equivalent doses requires professional guidance rather than self-comparison, as both represent different approaches to prescription weight management. Our clinical team at EverydayMeds assesses multiple factors including your BMI, medical history, lifestyle preferences, and practical considerations like travel requirements when recommending treatment options. The 3-minute online assessment captures essential information for prescriber review, ensuring safe and appropriate medication selection. Remember that both treatments work as part of a comprehensive weight management programme including dietary modifications and increased physical activity. Use code FIRST40 for new customers or DOSE25 for returning customers at checkout, with both Mounjaro and Wegovy available through our secure online platform. Explore both treatment options here and let our expert prescribers guide your decision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
